This inventor holds 1 USPTO granted patent. Top assignee: Sirnaomics, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Danny Tang
Introduction
Danny Tang is a prominent inventor based in Guangdong, China. He has made significant strides in the field of therapeutics, particularly in response to global health challenges. His work focuses on developing innovative solutions for the treatment of severe acute respiratory infections.
Latest Patents
Danny Tang holds a patent for his groundbreaking work titled "Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)." This patent includes compositions and methods for the development of potent siRNA therapeutics aimed at preventing and treating COVID-19 infections. The pharmaceutical compositions comprise siRNA cocktails that target critical viral genes, utilizing pharmaceutically acceptable polymeric nanoparticle carriers and liposomal nanoparticle carriers. The administration methods provided include airway instillation, subcutaneous injections, and nebulizer aerosolization.
Career Highlights
Danny Tang is associated with Sirnaomics, Inc., where he continues to push the boundaries of medical research and innovation. His work has been instrumental in addressing urgent health crises, showcasing his commitment to improving public health through scientific advancements.
Collaborations
Danny has collaborated with notable colleagues, including Xueping Chen and Patrick Y Lu, to further enhance the impact of his research and innovations.
Conclusion
Danny Tang's contributions to the field of therapeutics, particularly in the fight against COVID-19, highlight his role as a leading inventor. His innovative approaches and dedication to research continue to pave the way for advancements in medical science.